What is the most recent earnings date for UTHR stock?
UNITED THERAPEUTICS CORP (UTHR) last reported earnings on 2/25/2026.
UNITED THERAPEUTICS CORP (UTHR) Earnings History & Surprises
NASDAQ:UTHR • US91307C1027
Current stock price
589.37 USD
+8.86 (+1.53%)
Last:
UTHR Earnings overview
Past quarterly earnings results for UNITED THERAPEUTICS CORP (UTHR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $6.99
- Revenue Estimate
- 825.22M
Last Reported
Most Recent- Release Date
- Feb 25, 2026
- Period
- Q4 / 2025
- EPS Reported
- $7.70
- EPS Surprise
- 5.05%
- Revenue Surprise
- -4.72%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 7.70 | 7.33 | 5.05% | 24.39% | 790.2M | 829.34M | -4.72% | 7.38% |
| Q3 2025 | 7.16 | 7.33 | -2.35% | 12.05% | 799.5M | 831.21M | -3.81% | 6.76% |
| Q2 2025 | 6.41 | 7.08 | -9.46% | 9.57% | 798.6M | 820.37M | -2.65% | 11.71% |
| Q1 2025 | 6.63 | 6.66 | -0.45% | 7.46% | 794.4M | 744.42M | 6.71% | 17.22% |
| Q4 2024 | 6.19 | 6.44 | -3.83% | 41.97% | 735.9M | 749.44M | -1.81% | 19.72% |
| Q3 2024 | 6.39 | 6.55 | -2.49% | 18.77% | 748.9M | 737.03M | 1.61% | 22.89% |
| Q2 2024 | 5.85 | 6.53 | -10.35% | 11.64% | 714.9M | 705.7M | 1.30% | 19.85% |
| Q1 2024 | 6.17 | 5.76 | 7.04% | 26.95% | 677.7M | 636.44M | 6.48% | 33.70% |
| Q4 2023 | 4.36 | 4.27 | 2.12% | 63.30% | 614.7M | 587.39M | 4.65% | 25.07% |
| Q3 2023 | 5.38 | 5.14 | 4.59% | 9.57% | 609.4M | 598.84M | 1.76% | 18.10% |
| Q2 2023 | 5.24 | 4.60 | 14.02% | 117.43% | 596.5M | 534.65M | 11.57% | 27.76% |
| Q1 2023 | 4.86 | 4.62 | 5.31% | -3.38% | 506.9M | 524.66M | -3.39% | 9.74% |
| Q4 2022 | 2.67 | 4.60 | -41.99% | 13.62% | 491.5M | 529.59M | -7.19% | 18.38% |
| Q3 2022 | 4.91 | 3.97 | 23.61% | 43.57% | 516M | 503.07M | 2.57% | 16.03% |
| Q2 2022 | 2.41 | 4.22 | -42.84% | -33.97% | 466.9M | 470.28M | -0.72% | 4.57% |
| Q1 2022 | 5.03 | 3.41 | 47.41% | 724.59% | 461.9M | 428.42M | 7.81% | 21.84% |
| Q4 2021 | 2.35 | 3.79 | -38.00% | 7.31% | 415.2M | 436.17M | -4.81% | 7.87% |
| Q3 2021 | 3.42 | 3.66 | -6.66% | -11.40% | 444.7M | 429.88M | 3.45% | 17.00% |
| Q2 2021 | 3.65 | 3.08 | 18.49% | 51.45% | 446.5M | 386.11M | 15.64% | 23.34% |
| Q1 2021 | 0.61 | 3.00 | -79.67% | -80.45% | 379.1M | 376.33M | 0.74% | 6.40% |
| Q4 2020 | 2.19 | 3.20 | -31.60% | - | 384.9M | 369.28M | 4.23% | - |
| Q3 2020 | 3.86 | 2.89 | 33.66% | - | 380.1M | 365.63M | 3.96% | - |
| Q2 2020 | 2.41 | 2.93 | -17.70% | - | 362M | 346.77M | 4.39% | - |
| Q1 2020 | 3.12 | 2.80 | 11.23% | - | 356.3M | 351.21M | 1.45% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-1.80%
Max EPS beat (4)
5.05%
Min EPS beat (4)
-9.46%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-1.12%
Max Revenue beat (4)
6.71%
Min Revenue beat (4)
-4.72%
Analysis
In the last 4 quarters, UTHR has beaten EPS estimates in 1 out of 4 releases
UTHR has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, UTHR reported -1.8% below the EPS estimates on average.
In the last 4 quarters, UTHR reported -1.1% below the revenue estimates on average.
Related analysis
UNITED THERAPEUTICS CORP / UTHR Earnings FAQ
Did UNITED THERAPEUTICS CORP (UTHR) beat earnings estimates last quarter?
UNITED THERAPEUTICS CORP (UTHR) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does UNITED THERAPEUTICS CORP (UTHR) beat earnings estimates?
In the last 4 quarters, UNITED THERAPEUTICS CORP (UTHR) has beaten EPS estimates in 1 out of 4 releases.